Citigroup Maintains Buy on Herbalife, Lowers Price Target to $17

Benzinga Newsdesk www.benzinga.com Negative 57.7%

Neg 57.7% Neu 0% Pos 0%

Citigroup analyst Chasen Bender maintains Herbalife (NYSE:HLF) with a Buy and lowers the price target from $21 to $17.

Comments

No comments yet. Be the first!